Transcontinental Inc.
Transcontinental Inc. (TCLAF) Financial Performance & Income Statement Overview
Analyze Transcontinental Inc. (TCLAF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Transcontinental Inc. (TCLAF) Income Statement & Financial Overview
Analyze Transcontinental Inc.’s TCLAF earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $643.00M | $749.30M | $700.00M | $683.20M |
Cost of Revenue | $319.30M | $376.00M | $579.00M | $348.00M |
Gross Profit | $323.70M | $373.30M | $121.00M | $335.20M |
Gross Profit Ratio | $0.50 | $0.50 | $0.17 | $0.49 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $192.50M | $193.50M | $189.30M | $192.70M |
Operating Expenses | $235.00M | $294.00M | $51.80M | $280.60M |
Total Costs & Expenses | $554.30M | $670.00M | $630.80M | $628.60M |
Interest Income | $2.20M | -$900000.00 | $0.00 | $0.00 |
Interest Expense | $13.20M | $13.30M | $11.50M | $11.70M |
Depreciation & Amortization | $52.70M | $52.50M | $52.30M | $55.50M |
EBITDA | $145.30M | $129.00M | $117.40M | $88.00M |
EBITDA Ratio | $0.23 | $0.17 | $0.17 | $0.13 |
Operating Income | $88.70M | $79.30M | $69.20M | $33.20M |
Operating Income Ratio | $0.14 | $0.11 | $0.10 | $0.05 |
Other Income/Expenses (Net) | -$9.30M | -$16.10M | -$15.60M | -$14.40M |
Income Before Tax | $79.40M | $63.20M | $53.60M | $18.80M |
Income Before Tax Ratio | $0.12 | $0.08 | $0.08 | $0.03 |
Income Tax Expense | $23.70M | $15.20M | $9.80M | $2.80M |
Net Income | $55.60M | $47.90M | $43.60M | $15.90M |
Net Income Ratio | $0.09 | $0.06 | $0.06 | $0.02 |
EPS | $0.66 | $0.55 | $0.50 | $0.18 |
Diluted EPS | $0.66 | $0.55 | $0.50 | $0.18 |
Weighted Avg Shares Outstanding | $84.20M | $86.40M | $86.40M | $86.60M |
Weighted Avg Shares Outstanding (Diluted) | $84.20M | $86.40M | $86.40M | $86.60M |
Over the last four quarters, Transcontinental Inc.'s revenue moved from $683.20M in Q2 2024 to $643.00M in Q1 2025. Operating income in Q1 2025 was $88.70M, with a strong operating margin of 14%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Transcontinental Inc. remained robust at $145.30M, reflecting operational efficiency. Net income rose to $55.60M, with an EPS of $0.66. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan